Evidence map›Paper›PMID 41478298›Full record

ArticleJournal of dual diagnosis2026

Association Between Psychiatric Comorbidity and Retention in Substance Use Disorder Treatment: Results From Multi-Site Randomized Controlled Trials of Pharmacological and Behavioral Interventions.

Himani Byregowda, Masoumeh Amin-Esmaeili, Ryoko Susukida, Ramin Mojtabai, Rosa M Crum

Abstract read
In one paragraph

Article in Journal of dual diagnosis, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Himani ByregowdaDepartment of Mental Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
Masoumeh Amin-EsmaeiliDepartment of Mental Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
Ryoko SusukidaDepartment of Mental Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
Ramin MojtabaiDepartment of Mental Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
Rosa M CrumDepartment of Mental Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.

Funding

Substance Use Treatment Outcomes: Effect of Psychiatric ComorbidityR01DA058008 · NIDA · JOHNS HOPKINS UNIVERSITY · PI CRUM, ROSA M., MOJTABAI, RAMIN · 2023 to 2025
$1.1M
NIDA NIH HHS R01 DA058008
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Anxiety DisordersMood DisordersSubstance-Related DisordersAdultBehavior TherapyComorbidityDiagnosis, Dual (Psychiatry)FemaleHumansMaleMiddle AgedPsychological DistressRandomized Controlled Trials as Topicanxiety disorderscomorbiditymood disorderspsychiatric disorderspsychological distressSubstance use disordertreatment retention

Identifiers

PMID41478298
PMCPMC12961725

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.